Logo Logo
Hilfe
Hilfe
Switch Language to English

Kalfopoulou, Ermioni und Huebner, Johannes (2020): Advances and Prospects in Vaccine Development against Enterococci. In: Cells, Bd. 9, Nr. 11, 2397

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Enterococci are the second most common Gram-positive pathogen responsible for nosocomial infections. Due to the limited number of new antibiotics that reach the medical practice and the resistance of enterococci to the current antibiotic options, passive and active immunotherapies have emerged as a potential prevention and/or treatment strategy against this opportunistic pathogen. In this review, we explore the pathogenicity of these bacteria and their interaction with the host immune response. We provide an overview of the capsular polysaccharides and surface-associated proteins that have been described as potential antigens in anti-enterococcal vaccine formulations. In addition, we describe the current status in vaccine development against enterococci and address the importance and the current advances toward the development of well-defined vaccines with broad coverage against enterococci.

Dokument bearbeiten Dokument bearbeiten